Renhe Pharmacy Co., Ltd.

SZSE:000650.SZ

6.28 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

20242023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999199819971996199519941993
Revenue 4,074.8935,032.1465,153.2154,935.7554,106.1044,581.1724,403.4233,843.7713,567.0782,523.8432,253.2121,799.3762,087.5192,207.7091,366.781982.737876.461778.66524.943267.138280.391281.621220.813225.104236.129236.034192.647136.257169.474160.834132.181126.253
Cost of Revenue 2,528.8813,223.9593,266.2773,061.4152,456.0792,642.6512,510.6142,347.2112,261.0521,399.2111,222.746999.5121,265.2461,338.442659.806311.609445.141481.52635.389261.525281.372239.582189.194234.036195.585190.383147.489108.382129.956108.98985.49185.385
Gross Profit 1,546.0121,808.1881,886.9391,874.341,650.0251,938.5211,892.8091,496.5611,306.0271,124.6321,030.467799.864822.273869.267706.975671.128431.319297.139-10.4455.613-0.9842.03931.619-8.93240.54445.65145.15827.87539.51851.84546.69140.868
Gross Profit Ratio 0.3790.3590.3660.380.4020.4230.430.3890.3660.4460.4570.4450.3940.3940.5170.6830.4920.382-0.4190.021-0.0030.1490.143-0.040.1720.1930.2340.2050.2330.3220.3530.324
Reseach & Development Expenses 43.84976.98150.53752.14439.79438.04231.07735.91721.63612.8479.38513.5894.1111.7354.64400000000000000000
General & Administrative Expenses 77.71867.8168.59956.76152.84178.79585.46158.25927.94923.14436.23436.48239.17717.88121.07444.88127.22833.259-209.766128.10568.967133.32916.01212.16512.4486.4845.3924.9746.8777.3277.0685.785
Selling & Marketing Expenses 193.577540.433558.579596.23577.172788.469778.288618.604487.189373.214397.998331.071354.93387.952338.509403.346300.663204.8470.1040.8791.3242.7121.280.9241.5570.4360.2180.3920.2970.3640.6640.38
SG&A 271.295808.64627.178652.992630.012867.264863.749676.863515.138396.358434.232367.554394.107405.832359.583448.227327.891238.106-209.663128.98470.291136.04117.29213.08914.0056.925.615.3667.1737.6917.7326.165
Other Expenses 455.88360.577269.624224.81194.451219.5842.4380.7729.713.3498.8214.70536.2949.2991.726-0.7042.3516.841-48.0247.78418.18810.56211.6217.0710.474.027-0.0790.2323.5840.8661.0330.67
Operating Expenses 771.027946.198947.339929.945864.2571,124.891,130.281942.083751.982577.634608.609515.872515.898489.971420.015460.44333.985244.114-209.261130.50372.724138.76119.49414.46315.78.5166.5776.5757.998.5578.7666.836
Operating Income 774.986898.635953.2631,036.928860.514826.174752.864569.841550.222560.209415.337262.27309.014381.399288.198213.68395.98451.071179.628-122.203-68.81-100.4778.95-13.18625.74732.91534.316.71319.99626.13620.08419.112
Operating Income Ratio 0.190.1790.1850.210.210.180.1710.1480.1540.2220.1840.1460.1480.1730.2110.2170.110.0667.201-0.457-0.245-0.3570.041-0.0590.1090.1390.1780.1230.1180.1630.1520.151
Total Other Income Expenses Net -0.3670.2250.277-2.51-12.865-2.32.4380.778.64212.0317.00114.20736.04241.5691.432-0.88-73.676.841-48.468-7.745.896-0.007-0.111-0.276-0.33-0.295-0.08-0.1772.36000
Income Before Tax 774.618898.86953.541,034.418847.618823.874755.302570.613558.864572.24422.338276.478345.056390.669289.63212.79497.35557.912130.302-129.943-69.127-100.4848.839-13.46225.41732.6234.2216.53722.35726.13620.08419.112
Income Before Tax Ratio 0.190.1790.1850.210.2060.180.1720.1480.1570.2270.1870.1540.1650.1770.2120.2170.1110.0745.224-0.486-0.247-0.3570.04-0.060.1080.1380.1780.1210.1320.1630.1520.151
Income Tax Expense 208.033269.45241.983234.545189.961204.572171.216129.461128.073136.65198.48560.47668.91684.85663.93447.26927.19418.742-43.758-0.4336.3635.2714.546-0.7483.6294.8935.9160.1617.3788.6256.6286.307
Net Income 481.912567.257574.43665.025580.18537.827506.464380.227372.38391.304300.908194.183255.461300.353219.531165.49370.16139.17130.302-129.943-69.127-100.4848.839-12.71321.78827.72628.30416.37514.97917.51113.45712.805
Net Income Ratio 0.1180.1130.1110.1350.1410.1170.1150.0990.1040.1550.1340.1080.1220.1360.1610.1680.080.055.224-0.486-0.247-0.3570.04-0.0560.0920.1170.1470.120.0880.1090.1020.101
EPS 0.350.410.410.480.460.430.410.310.30.320.240.160.210.270.280.160.140.0430.14-0.14-0.075-0.110.008-0.0140.020.0270.0280.0180.0160.0190.0150.014
EPS Diluted 0.350.410.410.480.460.430.410.310.30.320.240.160.210.270.280.160.140.0430.14-0.14-0.075-0.110.008-0.0140.020.0270.0280.0180.0160.0190.0150.014
EBITDA 897.4391,050.6551,071.1181,124.97967.745911.972851.193662.112640.953606.973492.422342.818412.549422.447316.4242.381107.6566.184151.115-87.478-26.722-62.50348.67820.71543.49849.92550.10321.331.528-8.557-8.766-6.836
EBITDA Ratio 0.220.2090.2080.2280.2360.1990.1930.1720.180.240.2190.1910.1980.1910.2310.2470.1230.0856.058-0.327-0.095-0.2220.220.0920.1840.2120.260.1560.186-0.053-0.066-0.054